Published in Cancer Weekly, March 22nd, 2005
"Low serum high-density lipoprotein cholesterol (HDL-C) is an important component of the metabolic syndrome and has recently been related to increased breast cancer risk in overweight and obese women. We therefore questioned whether serum HDL-C might be a biologically sound marker of breast cancer risk," wrote Anne Sofie Furberg and colleagues, University of Tromso.
According to their report, "We obtained cross-sectional data among 206 healthy women ages 25 to 35 years who participated in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.